Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade

Blood. 2008 Sep 15;112(6):2463-73. doi: 10.1182/blood-2007-09-115477. Epub 2008 Jun 25.

Abstract

The D816V-mutated variant of Kit triggers multiple signaling pathways and is considered essential for malignant transformation in mast cell (MC) neoplasms. We here describe that constitutive activation of the Stat5-PI3K-Akt-cascade controls neoplastic MC development. Retrovirally transduced active Stat5 (cS5(F)) was found to trigger PI3K and Akt activation, and to transform murine bone marrow progenitors into tissue-infiltrating MCs. Primary neoplastic Kit D816V(+) MCs in patients with mastocytosis also displayed activated Stat5, which was found to localize to the cytoplasm and to form a signaling complex with PI3K, with consecutive Akt activation. Finally, the knock-down of either Stat5 or Akt activity resulted in growth inhibition of neoplastic Kit D816V(+) MCs. These data suggest that a downstream Stat5-PI3K-Akt signaling cascade is essential for Kit D816V-mediated growth and survival of neoplastic MCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells
  • Case-Control Studies
  • Cell Proliferation
  • Hematopoietic Stem Cells
  • Humans
  • Leukemic Infiltration
  • MAP Kinase Signaling System*
  • Mastocytosis, Systemic / pathology*
  • Mice
  • Mutation, Missense
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-kit / genetics
  • Proto-Oncogene Proteins c-kit / physiology*
  • STAT5 Transcription Factor / metabolism*

Substances

  • STAT5 Transcription Factor
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-kit
  • Proto-Oncogene Proteins c-akt